Eco Depot's construction subsidiary, Compañía Constructora de Tijuana (CCT), has secured approximately MXN 150 million (US$8.6 million) in contracts for two major Mexican infrastructure projects: the Olmeca Refinery at Dos Bocas and the Tren Maya railway. These contracts highlight CCT's expertise in civil construction and environmental services, enhancing Eco Depot's credibility for future projects. The company is also reviewing its corporate governance and capital structure, seeking an independent auditor to improve transparency and prepare for potential market upgrades or exchange listings. This strategic focus aims to build investor confidence and support sustainable growth.
Eco Depot's construction contracts provide context for readers. For those tracking Industrials, 73 of 135 US stocks rose, 58 fell on Pluang as of Oct 28, 2026 19:11 WIB. Notable movers include TE at USD 2.56 (+4.07%, 1-day hold, 79% buy), MTZ at USD 183.50 (+3.97%, 28-day hold, 100% buy), and PWR at USD 601.52 (+3.92%, 64-day hold, 100% buy).
On National First Responders Day, ADT celebrated local first responders and its monitoring professionals by unveiling a renovated monitoring center in Irving, Texas, part of a $2 million investment. The upgraded center features enhanced equipment and...
Cobalt Boats unveiled the 2027 265 Coastal Edition, a fully redesigned luxury outboard runabout tailored for coastal boating enthusiasts. Featuring wood-free construction, enhanced comfort, and advanced technology like dual 9-inch displays and option...
Presidio was named Enterprise Partner of the Year and Software and Services Partner of the Year for the Americas at the Cisco Partner Summit 2026. These awards recognize partners who excel in service and innovation, helping customers succeed through ...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
